Mohammed H Uddin (Md Hafiz Uddin)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 16

Top Venues

Clinical and translational medicine

Nature reviews. Clinical oncology

Cancers

Molecular cancer therapeutics

University of Dhaka (MSC)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Dhaka

Bangladesh

MSC :: Zoology (Parasitology)

University of Dhaka

Bangladesh

BSC :: Zoology (Parasitology)

Publications

Mohammed H Uddin, Mohammad Najeeb Al-Hallak, Husain Yar Khan, Amro Aboukameel, Yiwei Li, Sahar F Bannoura, Gregory Dyson, Seongho Kim, Yosef Mzannar, Ibrahim Azar, Tanya Odisho, Amr Mohamed, Yosef Landesman, Steve Kim, Rafic Beydoun, Ramzi M Mohammad, Philip A Philip, Anthony F Shields, Asfar S Azmi
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model. Clinical and translational medicine 13 (12) (2023)
Mohammed H Uddin, Mohammad Najeeb Al-Hallak, Husain Yar Khan, Amro Aboukameel, Yiwei Li, Sahar F Bannoura, Gregory Dyson, Seongho Kim, Yosef Mzannar, Ibrahim Azar, Tanya Odisho, Amr Mohamed, Yosef Landesman, Steve Kim, Rafic Beydoun, Ramzi M Mohammad, Philip A Philip, Anthony F Shields, Asfar S Azmi
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model. Clinical and translational medicine 13 (12) (2023)
Mohammed H Uddin, Mohammad Najeeb Al-Hallak, Husain Yar Khan, Amro Aboukameel, Yiwei Li, Sahar F Bannoura, Gregory Dyson, Seongho Kim, Yosef Mzannar, Ibrahim Azar, Tanya Odisho, Amr Mohamed, Yosef Landesman, Steve Kim, Rafic Beydoun, Ramzi M Mohammad, Philip A Philip, Anthony F Shields, Asfar S Azmi
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model. Clinical and translational medicine 13 (12) (2023)
Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, Osama Alkhalili, Mohammed H Uddin, Sahar F Bannoura, Yousef Mzannar, Ibrahim Hanna Azar, Eliza Wright Beal, Miguel Tobon, Steve H Kim, Rafic Beydoun, Erkan Baloglu, William Senapedis, Bassel F El-Rayes, Philip A Philip, Ramzi M Mohammad, Anthony Frank Shields, Mohammad Najeeb Al-Hallak, Asfar S Azmi
Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers. Molecular cancer therapeutics (2023)
Mohammed H Uddin, Mohammad Najeeb Al-Hallak, Husain Yar Khan, Amro Aboukameel, Yiwei Li, Sahar F Bannoura, Gregory Dyson, Seongho Kim, Yosef Mzannar, Ibrahim Azar, Tanya Odisho, Amr Mohamed, Yosef Landesman, Steve Kim, Rafic Beydoun, Ramzi M Mohammad, Philip A Philip, Anthony F Shields, Asfar S Azmi
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model. Clinical and translational medicine 13 (12) (2023)
Sahar F Bannoura, Amro Aboukameel, Husain Yar Khan, Mohammed H Uddin, Hyejeong Jang, Eliza Wright Beal, Amalraj Thangasamy, Seongho Kim, Kay-Uwe Wagner, Ramzi M Mohammad, Mohammad Najeeb Al-Hallak, Boris C Pasche, Asfar S Azmi
Regulator of Chromosome Condensation (RCC1) a novel therapeutic target in pancreatic ductal adenocarcinoma drives tumor progression via the c-Myc-RCC1-Ran axis. bioRxiv : the preprint server for biology (2023)
Mohammed H Uddin, Mohammad Najeeb Al-Hallak, Husain Yar Khan, Amro Aboukameel, Yiwei Li, Sahar F Bannoura, Gregory Dyson, Seongho Kim, Yosef Mzannar, Ibrahim Azar, Tanya Odisho, Amr Mohamed, Yosef Landesman, Steve Kim, Rafic Beydoun, Ramzi M Mohammad, Philip A Philip, Anthony F Shields, Asfar S Azmi
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model. Clinical and translational medicine 13 (12) (2023)
Mohammed H Uddin, Mohammad Najeeb Al-Hallak, Husain Yar Khan, Amro Aboukameel, Yiwei Li, Sahar F Bannoura, Gregory Dyson, Seongho Kim, Yosef Mzannar, Ibrahim Azar, Tanya Odisho, Amr Mohamed, Yosef Landesman, Steve Kim, Rafic Beydoun, Ramzi M Mohammad, Philip A Philip, Anthony F Shields, Asfar S Azmi
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model. Clinical and translational medicine 13 (12) (2023)
Mohammed H Uddin, Mohammad Najeeb Al-Hallak, Husain Yar Khan, Amro Aboukameel, Yiwei Li, Sahar F Bannoura, Gregory Dyson, Seongho Kim, Yosef Mzannar, Ibrahim Azar, Tanya Odisho, Amr Mohamed, Yosef Landesman, Steve Kim, Rafic Beydoun, Ramzi M Mohammad, Philip A Philip, Anthony F Shields, Asfar S Azmi
Molecular analysis of XPO1 inhibitor and gemcitabine-nab-paclitaxel combination in KPC pancreatic cancer mouse model. Clinical and translational medicine 13 (12) (2023)
Husain Yar Khan, Misako Nagasaka, Amro Aboukameel, Osama Alkhalili, Mohammed H Uddin, Sahar Bannoura, Yousef Mzannar, Ibrahim Azar, Eliza Beal, Miguel Tobon, Steve Kim, Rafic Beydoun, Erkan Baloglu, William Senapedis, Bassel El-Rayes, Philip A Philip, Ramzi M Mohammad, Anthony F Shields, Mohammed Najeeb Al-Hallak, Asfar S Azmi
Anticancer efficacy of KRASG12C inhibitors is potentiated by PAK4 inhibitor KPT9274 in preclinical models of KRASG12C mutant pancreatic and lung cancers. bioRxiv : the preprint server for biology (2023)
Husain Yar Khan, Mohammed H Uddin, Suresh Kumar Balasubramanian, Noor Sulaiman, Marium Iqbal, Mahmoud Chaker, Amro Aboukameel, Yiwei Li, William Senapedis, Erkan Baloglu, Ramzi M Mohammad, Jeffrey Zonder, Asfar S Azmi
PAK4 and NAMPT as Novel Therapeutic Targets in Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, and Mantle Cell Lymphoma. Cancers 14 (1) (2021)
Gabriel B Mpilla, Mohammed H Uddin, Mohammed N Al-Hallak, Amro Aboukameel, Yiwei Li, Steve H Kim, Rafic Beydoun, Gregory Dyson, Erkan Baloglu, William T Senapedis, Yosef Landesman, Kay-Uwe Wagner, Nerissa T Viola, Bassel F El-Rayes, Philip A Philip, Ramzi M Mohammad, Asfar S Azmi
PAK4-NAMPT Dual Inhibition Sensitizes Pancreatic Neuroendocrine Tumors to Everolimus. Molecular cancer therapeutics 20 (10) (2021)
Mohammed H Uddin, Yiwei Li, Husain Yar Khan, Irfana Muqbil, Amro Aboukameel, Rachel E Sexton, Shriya Reddy, Yosef Landesman, Trinayan Kashyap, Asfar S Azmi, Elisabeth I Heath
Nuclear Export Inhibitor KPT-8602 Synergizes with PARP Inhibitors in Escalating Apoptosis in Castration Resistant Cancer Cells. International journal of molecular sciences 22 (13) (2021)
Mohammed H Uddin, Mohammed Najeeb Al-Hallak, Philip A Philip, Ramzi M Mohammad, Nerissa Viola, Kay-Uwe Wagner, Asfar S Azmi
Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside. Cancers 13 (11) (2021)
Asfar S Azmi, Mohammed H Uddin, Ramzi M Mohammad
The nuclear export protein XPO1 - from biology to targeted therapy. Nature reviews. Clinical oncology 18 (3) (2020)
Asfar S Azmi, Mohammed H Uddin, Ramzi M Mohammad
Author Correction: The nuclear export protein XPO1 - from biology to targeted therapy. Nature reviews. Clinical oncology (2020)

Mohammed H Uddin.css-eqlu8i{font-size:small;padding-left:4px;} (Md Hafiz Uddin)

Publication Activity (10 Years)

Top Topics

Top Venues

Mohammed H Uddin (Md Hafiz Uddin)